Farzanbakhsh S, Amini MR, Madani H, Sadri B, et al. Safety evaluation of bi-layered allogenic keratinocyte and fibroblast skin substitute for diabetic foot ulcers-SAFESKIN-DFU: A Phase 1 clinical trial. Diabetes Obes Metab 2024 Aug 19. doi: 10.1111/dom.15843.
PMID: 39161059